Journal of Symptoms and Signs

Journal of Symptoms and Signs is a peer-reviewed, open access journal that publishes original articles, review articles and case reports related to all aspects of symptom control and treatment. The aim of the Journal is to improve the level of learners in reading and understanding signs and symptoms today.

Journal of Symptoms and Signs is included in the following databases/resources:

Chemical Abstract

Directory of Research Journals Indexing

Directory of Science

Google Scholar

NLM Catalog

ResearchBib Journal database



New research conclusions


Afamelanotide had an acceptable side-effect and adverse-event profile and was associated with an increased duration of sun exposure without pain and improved quality of life in patients with erythropoietic protoporphyria. N Engl J Med 2015; 373:48-59

3.0 mg of liraglutide, as an adjunct to diet and exercise, was associated with reduced body weight and improved metabolic control.

N Engl J Med 2015; 373:11-22

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)- BMI at diagnosis was a statistically significant prognostic factor in a group of patients receiving optimally dosed chemotherapy. Additional research is needed to determine the impact of weight loss on breast cancer outcomes and to evaluate whether this impact is maintained across tumor subtypes. JNCI J Natl Cancer Inst (2015) 107 (9):  djv179. doi: 10.1093/jnci/djv179

Stroke following percutaneous coronary intervention: Incident ischaemic stroke complications have increased over time, whilst haemorrhagic stroke complications have decreased, driven through changes in clinical, procedural, drug-treatment, and demographic factors. Both ischaemic and haemorrhagic strokes are rare but devastating complications with high 30-day mortality and in-hospital major adverse cardiovascular events rates. DOI: 1618-1628 First published online: 20 April 2015

Major modifiable cardiovascular risk factors (elevated cholesterol levels, diabetes, hypertension, obesity, and smoking) collectively accounted for half of cardiovascular deaths in U.S. adults aged 45 to 79 years in 2009 to 2010. Ann Intern Med.  Published online 30 June 2015 doi:10.7326/M14-1753

Posted: 2015-06-18

Call for Paper


Journal of Symptoms and Signs (JSS) invite you to contribute new research articles, review articles, expert opinions or case reports for inclusion in the publication.

Among topics to be included (but not limited) are the following:

Efficacy or safety of new drugs;

Epidemiology of signs and symptoms;

Symptoms to diagnosis;

Signs, symptoms and radiology;

Early symptoms and signs of diseases;

Signs and symptoms of adverse effects;

Symptom control in clinic or critical care setting;

Hospice care


Posted: 2014-10-29
More Announcements...

Vol 4, No 2 (2015)

Table of Contents

Expert Opinion

The use of aprepitant in the prevention of post-operative and postdischarge nausea and vomiting PDF
M. Kyle Ritchie, Manuel C. Vallejo 64-70
Efficacy and safety of temsirolimus in renal cell carcinoma PDF
Soundouss Raissouni, Richard Lee-Ying, Michael M. Vickers 71-76
Efficacy and safety of edoxaban in the treatment of venous thromboembolism PDF
Marianne Brodmann, Thomas Gary, Ernst Pilger 77-80
Somatostatin analogues: Therapeutic applications for pituitary and gastroenteropancreatic neuroendocrine tumors PDF
Olga Karapanou, Marinella Tzanela, Stylianos Tsagarakis 81-92
Lanthanum carbonate in daily clinical practice PDF
Maria Dolores Arenas Jiménez 93-97
Efficacy and safety of tamsulosin for the treatment of lower urinary tract symptoms PDF
Stefano Palea 98-106
Efficacy and safety of pitavastatin PDF
Masahiro Ohira, Kohji Shirai, Ichiro Tatsuno 107-117

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


Articles featured on this website are opinion pieces composed by the authors, and not necessarily those of the editors or Journal of Symptoms and Signs. While every effort is made to ensure that the content of this website is accurate, the website is provided “as is” and Journal of Symptoms and Signs makes no representations or warranties in relation to the accuracy or completeness of the information found on it. While the content of this site is provided in good faith, we do not warrant that the information will be kept up to date, be true and not misleading, or that this site will always be available for use.

Journal of Symptoms and Signs

ISSN 2309-6195